Literature DB >> 26870200

Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.

Zhenshan Shi1, Qian Zhuang2, Ruixiong You1, Yueming Li1, Jian Li1, Dairong Cao1.   

Abstract

Patients with renal medullary carcinoma (RMC) have a poor prognosis, usually due to late diagnosis. Computed tomography (CT) analysis may aid the differentiation between RMC and other types of renal cell carcinoma, in order to establish an accurate early diagnosis. There is a limited number of reports in the literature focusing on clinical and multi-slice CT (MSCT) imaging findings of RMC. Consequently, the present study aimed to characterize the clinical and MSCT imaging features of RMC. For this purpose, the MSCT imaging findings of 6 patients with RMC were retrospectively studied. The patients were subjected to MSCT in order to investigate the characteristics of the tumors, including location, size, density, calcification, cystic or solid appearance, capsule sign, enhancement pattern and presence of retroperitoneal lymph node metastasis. The tumors in the current study presented a mean diameter of 7.48±3.25 cm, and were observed to be solitary and heterogeneous with necrotic components. The majority of the tumors did not contain calcifications (5/6); displayed an ill-defined margin (4/6); were centered in the medulla; extended into the renal pelvis or peripelvic tissues (6/6); and did not exhibit a fibrous capsule. Localized caliectasis was observed in 3 of the 6 cases. The attenuation of the solid region of the RMC on unenhanced CT was equal to that of the renal cortex or medulla (42.3±2.7 vs. 40.7±3.6 and 41.2±3.9 Hounsfield units, respectively; P>0.05) while, on enhanced CT, the enhancement of the tumor was lower than that of the normal renal cortex and medulla during all phases (cortical phase, 52.6±4.8 vs. l99.5±9.7 and 72.7±6.4; medullary phase, 58.6±5.7 vs. 184.6±10.8 and 93.5±7.8; delayed phase, 56.8±6.1 vs. 175.7±8.5 and 96.5±7.9, respectively; P<0.05). In conclusion, RMC tends to be an infiltrative, ill-defined heterogeneous mass with intratumoral necrosis, which arises from the renal medulla, and displays lower enhancement than the renal cortex and medulla during all phases on enhanced CT. Despite its rarity in adults, RMC should be included in a differential diagnosis when CT imaging reveals these features.

Entities:  

Keywords:  kidney neoplasm; multi-slice computed tomography; renal medullary carcinoma

Year:  2015        PMID: 26870200      PMCID: PMC4727026          DOI: 10.3892/ol.2015.3891

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Renal medullary carcinoma: can early diagnosis lead to long-term survival?

Authors:  D M Selby; C Simon; J P Foley; I M Thompson; R T Baddour
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

2.  Renal medullary carcinoma.

Authors:  Erica L Steele; Gregory T MacLennan
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

3.  Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Authors:  Nicole Hindman; Long Ngo; Elizabeth M Genega; Jonathan Melamed; Jesse Wei; Julia M Braza; Neil M Rofsky; Ivan Pedrosa
Journal:  Radiology       Date:  2012-09-25       Impact factor: 11.105

4.  Renal medullary carcinoma and ABL gene amplification.

Authors:  Lijo Simpson; Xiang He; Michael Pins; Xiaoke Huang; Steven C Campbell; Ximing J Yang; Elizabeth J Perlman; Raymond C Bergan
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

5.  Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.

Authors:  Edward M Schaeffer; Thomas J Guzzo; Kyle A Furge; George Netto; Michael Westphal; Karl Dykema; Ximing Yang; Ming Zhou; Bin Tean Teh; Christian P Pavlovich
Journal:  BJU Int       Date:  2009-12-11       Impact factor: 5.588

6.  Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.

Authors:  Qingyan Liu; Susanna Galli; Ramaprasad Srinivasan; William Marston Linehan; Maria Tsokos; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

7.  Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features.

Authors:  S L Strobel; W S Jasper; S A Gogate; H M Sharma
Journal:  Arch Pathol Lab Med       Date:  1984-09       Impact factor: 5.534

Review 8.  Renal medullary carcinoma: the Bronx experience.

Authors:  A Ari Hakimi; Phillip T Koi; Paul M Milhoua; Netta M Blitman; Maomi Li; Vladimir Hugec; Janice P Dutcher; Reza Ghavamian
Journal:  Urology       Date:  2007-11       Impact factor: 2.649

9.  Collecting duct carcinoma of the kidney. A contribution of 4 new cases.

Authors:  Manuel Soto Delgdo; Gema Pedrero Márquez; Jose Miguel Arroyo Maestre; Pastora Beardo Villar
Journal:  Arch Esp Urol       Date:  2014-10       Impact factor: 0.436

10.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

View more
  9 in total

1.  Nutcracker Syndrome and Sickle Cell Trait.

Authors:  Sean Verma; Mustafa Khaliqi; Kellee L Oller
Journal:  J Gen Intern Med       Date:  2017-11       Impact factor: 5.128

Review 2.  Renal Medullary Carcinoma: Establishing Standards in Practice.

Authors:  Kathryn E Beckermann; Deva Sharma; Shruti Chaturvedi; Pavlos Msaouel; Miguel R Abboud; Yves Allory; Franck Bourdeaut; Julien Calderaro; Aguirre A de Cubas; Vimal K Derebail; Andrew L Hong; Rakhi P Naik; Gabriel G Malouf; Elizabeth A Mullen; Victor E Reuter; Charles W M Roberts; Cheryl L Walker; Christopher G Wood; Michael R DeBaun; Hendrik Van Poppel; Nizar M Tannir; W Kimryn Rathmell
Journal:  J Oncol Pract       Date:  2017-07       Impact factor: 3.840

3.  Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.

Authors:  Jesse K Sandberg; Elizabeth A Mullen; Mariana M Cajaiba; Ethan A Smith; Sabah Servaes; Elizabeth J Perlman; James I Geller; Peter F Ehrlich; Nicholas G Cost; Jeffrey S Dome; Conrad V Fernandez; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2017-07-08

Review 4.  Recent Advances in Renal Medullary Carcinoma.

Authors:  Yongdong Su; Andrew L Hong
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

Review 5.  Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives.

Authors:  Ellen M Chung; Grant E Lattin; Kimberly E Fagen; Andrew M Kim; Michael A Pavio; Adam J Fehringer; Richard M Conran
Journal:  Radiographics       Date:  2017 Sep-Oct       Impact factor: 5.333

6.  Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition.

Authors:  Quaovi Sodji; Kandy Klein; Kavuri Sravan; Jigarkumar Parikh
Journal:  J Immunother Cancer       Date:  2017-08-15       Impact factor: 13.751

7.  Renal Medullary Carcinoma with an Aggressive Clinical Course: A Case Report and Review of the Literature.

Authors:  Madhumati R Kalavar; Sami Ali; Damoun Safarpour; Saroj Davi Kunnakkat
Journal:  Case Rep Oncol       Date:  2017-01-06

Review 8.  Imaging of Renal Medullary Carcinoma.

Authors:  Federico Greco; Eliodoro Faiella; Domiziana Santucci; Carlo Augusto Mallio; Marco Nezzo; Carlo Cosimo Quattrocchi; Bruno Beomonte Zobel; Rosario Francesco Grasso
Journal:  J Kidney Cancer VHL       Date:  2017-03-21

9.  Renal medullary carcinoma masquerading as renal infection: a case report.

Authors:  Zhong-Ming Huang; Hai Wang; Zhi-Gang Ji
Journal:  BMC Nephrol       Date:  2020-03-05       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.